Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
์ข
๋ชฉ ์ฝ๋ CTKB
ํ์ฌ ์ด๋ฆCytek Biosciences Inc
์์ฅ์ผJul 23, 2021
CEOJiang (Wenbin)
์ง์ ์648
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃJul 23
์ฃผ์47215 Lakeview Boulevard
๋์FREMONT
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ94538
์ ํ18779229835
์น์ฌ์ดํธhttps://cytekbio.com
์ข
๋ชฉ ์ฝ๋ CTKB
์์ฅ์ผJul 23, 2021
CEOJiang (Wenbin)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์